Euvascor - modern combination therapy for patients with arterial hypertension and dyslipidemia (new fixed combination therapy of atorvastatin and perindopril)
2019
Abstract
Cardiovascular disease is one of the most common causes of mortality and morbidity in our countries. We can reduce this risk using targeted intervention of all risk factors, as evidenced by statistics over past 30 years.
However, the targeted pharmacotherapy of all risk factors leads to a polypharmacy with which our patients' adherence to pharmacotherapy decreases. The advantage is fixed combinations.
Nowadays we have a fixed combination of two risk factors for atherosclerosis: dyslipidemia and arterial hypertension - Euvascor.